FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Buprenorphine 35micrograms/hour transdermal patch Ambiguous
Buprenorphine 52.5micrograms/hour transdermal patch Ambiguous
Buprenorphine 52.5micrograms/hour transdermal patch Ambiguous
Buprenorphine 5microgram/hour transdermal patch A component that is no longer current, useful, appropriate or acceptable.
Buprenorphine 70micrograms/hour transdermal patch Ambiguous
Buprenorphine 70micrograms/hour transdermal patch Ambiguous
Buprenorphine hydrochloride + naloxone hydrochloride Erroneous component (foundation metadata concept)
Buprenorphine hydrochloride 2mg + naloxone hydrochloride 0.5mg sublingual tablet A component that is no longer current, useful, appropriate or acceptable.
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet A component that is no longer current, useful, appropriate or acceptable.
Buprenorphine overdose of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Buprenorphine poisoning of undetermined intent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Buprenorphine product A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bupropion A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bupropion contraindicated A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bupropion contraindicated A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bupropion hydrochloride 100mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 100mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 150mg m/r tablet Ambiguous
Bupropion hydrochloride 150mg m/r tablet Ambiguous
Bupropion hydrochloride 200mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 200mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 300mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 300mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 50mg m/r tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion hydrochloride 50mg prolonged-release oral tablet A component that is no longer current, useful, appropriate or acceptable.
Bupropion m/r tablet A component that fails to comply with the current editorial guidance.
Bupropion refused A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bupropion refused A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burette intravenous administration set A component that fails to comply with the current editorial guidance.
Burglar A component that fails to comply with the current editorial guidance.
Burial occupation NOS Classification derived component
Burial occupation NOS Classification derived component
Buriats A component that fails to comply with the current editorial guidance.
Burkholderia A component that is no longer current, useful, appropriate or acceptable.
Burkholderia cocovenenans A component that is no longer current, useful, appropriate or acceptable.
Burkholderia mallei Ambiguous
Burkholderia species Ambiguous
Burkholderia vandii A component that is no longer current, useful, appropriate or acceptable.
Burkitt lymphoma of lymph nodes of axilla and upper limb A component that fails to comply with the current editorial guidance.
Burkitt lymphoma of lymph nodes of inguinal region and lower limb A component that fails to comply with the current editorial guidance.
Burkitt's lymphoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burkitt's lymphoma NOS Limited component (foundation metadata concept)
Burkitt's lymphoma associated with acquired immunodeficiency syndrome Ambiguous
Burkitt's lymphoma of lymph nodes of head, face and neck A component that fails to comply with the current editorial guidance.
Burkitt's lymphoma of unspecified site Limited component (foundation metadata concept)
Burkitt's tumor of extranodal AND/OR solid organ site Classification derived component
Burkitt's tumor of intra-abdominal lymph nodes A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burkitt's tumor of intrapelvic lymph nodes A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burkitt's tumor of intrathoracic lymph nodes A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burkitt's tumor of lymph nodes of axilla AND/OR upper limb A component that fails to comply with the current editorial guidance.
Burkitt's tumor of lymph nodes of head, face AND/OR neck A component that fails to comply with the current editorial guidance.
Burkitt's tumor of lymph nodes of inguinal region AND/OR lower limb A component that fails to comply with the current editorial guidance.
Burkitt's tumor of lymph nodes of multiple sites A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burkitt's tumor of spleen A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burlina cattle breed Moved elsewhere
Burmese cat Moved elsewhere
Burmese cattle breed Moved elsewhere
Burmese fairy bluebird Ambiguous
Burmese pig breed Moved elsewhere
Burn - cornea - eye Ambiguous
Burn - face &/or head &/or neck Ambiguous
Burn - face &/or head &/or neck Ambiguous
Burn - intestinal organs Ambiguous
Burn - intestinal organs Ambiguous
Burn - larynx &/or trachea &/or lung Ambiguous
Burn - larynx &/or trachea &/or lung Ambiguous
Burn - leg &/or foot Ambiguous
Burn - leg &/or foot Ambiguous
Burn - unspecified Classification derived component
Burn - unspecified Classification derived component
Burn - vagina &/or uterus Ambiguous
Burn - vagina &/or uterus Ambiguous
Burn - wrist &/or hand Ambiguous
Burn - wrist &/or hand Ambiguous
Burn as a percentage of body surface involved NOS Limited component (foundation metadata concept)
Burn confined to eye and adnexa NOS Limited component (foundation metadata concept)
Burn dressing Ambiguous
Burn dressing Ambiguous
Burn erythema of face AND/OR head Ambiguous
Burn erythema of face, head AND/OR neck Ambiguous
Burn erythema of forehead AND/OR cheek Ambiguous
Burn erythema of multiple sites of trunk A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Burn erythema of multiple sites of wrist AND/OR hand Ambiguous
Burn erythema of single finger, not thumb Ambiguous
Burn erythema of two OR more fingers including thumb Ambiguous
Burn erythema of two OR more fingers not including thumb Ambiguous
Burn involving 10-14 percent of body surface, with 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 10-14 percent of body surface, with 10-14 percent of body surface with full thickness burn Erroneous component (foundation metadata concept)
Burn involving 10-14% of body surface A component that fails to comply with the current editorial guidance.
Burn involving 15-19 percent of body surface, with 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 15-19 percent of body surface, with 10-19 percent of body surface with full thickness burn Erroneous component (foundation metadata concept)
Burn involving 15-19% of body surface A component that fails to comply with the current editorial guidance.
Burn involving 20-29 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 30-39 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 40-49 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 50-59 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 60-69 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 70-79 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving 80-89 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)
Burn involving greater than 90% of body surface NOS Limited component (foundation metadata concept)
Burn involving less than 10 percent of body surface, with less than 10 percent or unspecified percentage of body surface with full thickness burn Limited component (foundation metadata concept)

Start Previous Page 201 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start